PM
Prosight Management Portfolio holdings
AUM
$410M
This Quarter Return
-13.99%
1 Year Return
-14.96%
3 Year Return
+21.81%
5 Year Return
+1.17%
10 Year Return
–
AUM
$179M
AUM Growth
+$179M
(-8.8%)
Cap. Flow
+$10.5M
Cap. Flow
% of AUM
5.87%
Top 10 Holdings %
Top 10 Hldgs %
59.55%
Holding
44
New
5
Increased
14
Reduced
14
Closed
10
Top Buys
| 1 |
United Therapeutics
UTHR
|
$9.92M |
| 2 |
uniQure
QURE
|
$8.23M |
| 3 |
MeiraGTx Holdings
MGTX
|
$5.39M |
| 4 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$3.65M |
| 5 |
AC Immune
ACIU
|
$3.39M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$5.35M |
| 2 |
Zimmer Biomet
ZBH
|
$5.03M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$5.01M |
| 4 |
Q32 Bio
QTTB
|
$3.91M |
| 5 |
Indaptus Therapeutics
INDP
|
$3.54M |
Sector Composition
| 1 | Healthcare | 97.96% |
| 2 | Industrials | 2.04% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TLGT
26
DELISTED
Teligent, Inc
TLGT
| $2.32M | 1.29% |
2,446,043
-521,678
| -18% | -$495K |
|
|
CLVS
27
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.31M | 1.28% |
587,626
+137,626
| +31% | +$541K |
|
28
Personalis
PSNL
$430M
| $1.69M | 0.94% |
115,214
+58,768
| +104% | +$863K |
|
29
Cigna
CI
$80.2B
| $1.67M | 0.93% |
11,000
-20,227
| -65% | -$3.07M |
|
|
MTEM
30
DELISTED
Molecular Templates, Inc.
MTEM
| $1.47M | 0.82% |
222,994
+25,313
| +13% | +$167K |
|
|
UROV
31
DELISTED
Urovant Sciences Ltd.
UROV
| $972K | 0.54% |
102,657
-39,963
| -28% | -$378K |
|
|
SRRA
32
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $924K | 0.51% |
2,366,707
-314,911
| -12% | -$123K |
|
33
Tempest Therapeutics
TPST
$46.6M
| $370K | 0.21% |
52,051
-21,817
| -30% | -$155K |
|
34
Evolus
EOLS
$477M
| – | – |
-112,590
| Closed | -$1.65M |
|
35
Cidara Therapeutics
CDTX
$1.61B
| – | – |
-358,963
| Closed | -$603K |
|
36
Assembly Biosciences
ASMB
$183M
| – | – |
-200,000
| Closed | -$2.7M |
|
37
ASGN Inc
ASGN
$2.35B
| – | – |
-30,000
| Closed | -$1.82M |
|
|
WCG
38
DELISTED
Wellcare Health Plans, Inc.
WCG
| – | – |
-6,500
| Closed | -$1.85M |
|
|
NVRO
39
DELISTED
NEVRO CORP.
NVRO
| – | – |
-11,000
| Closed | -$713K |
|
40
Neurogene
NGNE
$284M
| – | – |
-3,637
| Closed | -$9K |
|
|
MODV
41
DELISTED
ModivCare
MODV
| – | – |
-14,677
| Closed | -$842K |
|
42
Kezar Life Sciences
KZR
$28.5M
| – | – |
-34,224
| Closed | -$264K |
|
|
43
Indaptus Therapeutics
INDP
$5.98M
| – | – |
-815,789
| Closed | -$3.54M |
|
44
Exact Sciences
EXAS
$9.33B
| – | – |
0
| – | – |
|